MRD / Regn No. : TL/20-21/00269 Date : 20/07/2026
Patient Name : Sunil Kumar Saxena Age & Gender : 57 Yrs. / Male
Contact No. : 7718800573 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : PANCREATIC DIABETES (04/May/2021) |
Subjective : PANCREATIC ISSUES,SO SWITCHED FROM JALRA M TO UDAPA,ANGIOPLASTY IN APRIL 2023,ACS / INF WALL MI,RECOVERED THYROIDITIS,DIABETES DURATION 20 YEARS
Objective : 17-JUL-2026 REPORTS,T PSA-2.270,TSH-3.300,TC-125/ TG-184/ LDL-60/ HDL-47,ALT-26/ AST-30,CR-0.9,FBS-128/ PPBS-255,HB-13.5
Analysis : AXCER / ATORVA EZ / ECOSPRIN 75 / OZOTEL AM 40/5
Plan : GLP1 ANALOG / DPPIV MAY BE CONSIDERED AFTER PANCREATIC EVLAUATION  
S# Generic (Trade) Name Route Dosage Usage Duration
1 UDAPA - M 10/500 MG ORAL 1-0-0 ABF
3 MTHS
2 MECOFOL OD ORAL 1-0-0 ALTERNATE DAY
TO CONTINUE
3 DRISE 60,000 ORAL 1/MTH ANYTIME OF DAY
TO CONTINUE
4 TABLET GLIMEPIRIDE (1MG) AND METFORMIN (500MG)
GEMER 1
ORAL 0-0-1 BD
3 MTHS
5 GEMER 2 ORAL 1-0-0 BBF
3 MTHS
6 LUPIMEG 500 MG ORAL 1-0-1 ABF / AD
10 DAYS
7 LUPIMEG 1 GM ORAL 1-0-1 ABF / AD
3 MTHS
       
Refill : 0 / Substitution:    
Education : TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.
Next Visit : 08/Jul/2026
Tests Suggested For Next Visit : HBA1C > 6 WEEKS - IF DROPS FROM 8.5 BY 0.5 TO 0.7% THEN CONTINUE SAME MEDS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: